CNBC's Fast Money team takes a look at five technology stocks that are set to fly higher.» Read More
This hot biotech play is up more than 40 percent, and Jim Cramer thinks it's time to rake in profits.
Are coal stocks the ultimate energy value play, or should bottom-fishing stock pickers stay far away?
Tiffany cut its guidance after reporting flat global holiday sales, but one pro says that doesn't mean there's trouble in high-end retail.
Twitter could easily be snatched up by Google, argues options trader Dan Nathan. Here's how to play for that possibility.
Tiffany reported flat holiday sales for 2014, bucking the trend of decent revenue numbers from other retailers.
Check out which companies are making headlines after the bell Monday: AA, F, RSH & more.
The good times aren't over yet for the stock market, says floor trader Kenny Polcari. But buckle up—it could be a bumpy ride!
CNBC's Jim Cramer says analysts need to cut their oil outlook in order for energy stocks to bottom.
Layoffs and selloffs have hit the nation's small and midsize oil and gas producers as millions are being withdrawn from 2015 projects.
Josh Brown makes the first trade of CNBC's "Halftime" Portfolio Challenge.
Billionaire buy-and-hold investor Ron Baron tells CNBC he expects big things from Tesla Motors and Manchester United.
The 14 money managers in the inaugural Squawk Box Portfolio challenge see better times ahead for the few nonindexers left on Wall Street in 2015.
Jim Cramer sees we are in volatile market territory this year, and he gives the stocks he will be watching next week.
Some of the names on the move ahead of the open.
The "Fast Money" traders give their final trades of the day.
These 10 tips can help you navigate the mortgage process in 2015.
Jim Cramer agrees with Peltz about a breakup for Dupont. Here's how to play it.
Art Cashin, UBS' director of floor operations at the NYSE, told CNBC that what happened in Paris did not shake the markets.
Retail analyst Stacey Widlitz says that layoffs have been a long time coming in an industry with too many stores.
History says the best play is to buy biotech stocks the day before the JPMorgan meeting starts and hold until the end.